Related Experiment Video

Updated: May 20, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

A critical review of lipid-based nanoparticles for taxane delivery

Lan Feng1, Russell J Mumper

  • 1Center for Nanotechnology in Drug Delivery, Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Cancer Letters
|July 17, 2012
PubMed

Insights

Lipid-based nanoparticles offer a promising strategy for delivering hydrophobic anticancer drugs like taxanes, overcoming limitations of conventional treatments and improving efficacy in solid tumors.

Area of Science:

  • Nanomedicine
  • Drug Delivery
  • Oncology

Background:

  • Conventional anticancer drugs, particularly taxanes, face challenges like low therapeutic index and poor delivery to solid tumors.
  • Hydrophobic taxanes require advanced delivery systems due to their poor solubility.
  • Nano-based delivery systems have emerged as a key strategy to address these limitations.

Purpose of the Study:

  • To provide a comprehensive overview of lipid-based nanoparticles for taxane delivery.
  • To discuss the drawbacks of current taxane formulations.
  • To outline criteria for an ideal taxane delivery system.

Main Methods:

  • Critical review of preclinical studies on nano-based formulations for taxanes.
  • Analysis of existing taxane formulations and their limitations.
  • Discussion of the properties and advantages of lipid-based nanoparticles.

Main Results:

  • Lipid-based nanoparticles are a viable alternative for delivering hydrophobic taxanes.
  • Significant advancements have been made in developing nano-formulations for taxanes.
  • Current formulations present specific drawbacks that necessitate improved delivery strategies.

Conclusions:

  • Lipid-based nanoparticles represent a significant advancement in taxane delivery for cancer therapy.
  • Further development is needed to optimize these systems based on defined criteria.
  • These systems hold potential to enhance the therapeutic efficacy of taxanes.

More Related Videos

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...